ETRAVIRINE 100 MG TABLET

etravirine
$7.7671per EA

Strength

100 mg/1

NDC

10147057001

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

3/18/2026

Active Ingredients

ETRAVIRINE

Approval Type

New Drug (NDA)

FDA Application

NDA022187

On Market Since

4/1/2025

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
P-Glycoprotein Inhibitors

Price History

1W

0.0%

1M

0.0%

3M

-3.1%

6M

-2.1%

1Y

N/A

3Y

N/A

5Y

N/A

All

-6.1%